Literature DB >> 8083129

Randomized trial comparing preoperative versus postoperative irradiation for prevention of heterotopic ossification following prosthetic total hip replacement: preliminary results.

S J Gregoritch1, M Chadha, V D Pelligrini, P Rubin, D A Kantorowitz.   

Abstract

PURPOSE: Previous in vivo data support effectiveness of preoperative irradiation in suppressing heterotopic ossification (HTO) in a rat model. A prospectively randomized, multiinstitution clinical trial to assess the comparative efficacy of preoperative vs. postoperative irradiation in preventing HTO in total hip replacement patients was undertaken. METHODS AND MATERIALS: One hundred and twenty-two patients (124 hips) with significant risk factors for HTO following elective total hip replacement were randomized to receive irradiation via either preoperative (< 4 h before surgery) or "standard" postoperative (< 48 h after surgery) schedules. Single 7-8 Gy fractions were administered. Treatment volume included soft tissues between periacetabular region of pelvis and intertrochanteric portion of femur. All but nine patients had biologic fixation prostheses, the porous-coated portions of which were shielded. Radiographs of treated hips were obtained immediately and at 2 and 6 months postsurgery. Heterotopic ossification was scored according to the Brooker Grading system.
RESULTS: Ninety-eight patients are evaluable (55 preoperative, 43 postoperative) with median follow-up of 38 weeks. No significant differences were noted in the incidence of overall HTO (26% preoperative vs. 28% postoperative, p = 1.0) or clinically significant Brooker grade 3 or 4 HTO (2% preoperative vs. 5% postoperative, p = 0.58). No significant differences in treatment variables (including time interval between preoperative irradiation and surgery) were evident on comparing preoperatively treated patients forming HTO with those who did not.
CONCLUSION: Prophylactic irradiation of the operative site within 4 h prior to elective total hip replacement appears to be comparably effective to the currently accepted postoperative treatment schedules in prevention of clinically significant HTO about the hip. This finding is of importance in terms of patient comfort, ease of treatment, and avoidance of possible complications associated with moving the patient to the radiotherapy department in the immediate postoperative period.

Entities:  

Mesh:

Year:  1994        PMID: 8083129     DOI: 10.1016/0360-3016(94)90519-3

Source DB:  PubMed          Journal:  Int J Radiat Oncol Biol Phys        ISSN: 0360-3016            Impact factor:   7.038


  18 in total

Review 1.  Prevention of heterotopic ossification after total hip replacement with NSAIDs.

Authors:  Roel Fijn; Rinco Th Koorevaar; Jacobus R Brouwers
Journal:  Pharm World Sci       Date:  2003-08

Review 2.  Radiation therapy for the treatment of benign vascular, skeletal and soft tissue diseases.

Authors:  A Montero Luis; R Hernanz de Lucas; A Hervás Morón; E Fernández Lizarbe; S Sancho García; C Vallejo Ocaña; A Polo Rubio; A Ramos Aguerri
Journal:  Clin Transl Oncol       Date:  2008-06       Impact factor: 3.405

3.  [Heterotopic ossifications in total hip arthroplasty: prophylaxis and therapy].

Authors:  J Schauwecker; F Pohlig; A Toepfer; H Gollwitzer; R von Eisenhart-Rothe
Journal:  Orthopade       Date:  2011-06       Impact factor: 1.087

4.  [Radiation therapy to prevent heterotopic ossification: example of a clinical trial].

Authors:  M H Seegenschmiedt
Journal:  Strahlenther Onkol       Date:  1997-12       Impact factor: 3.621

5.  The effect of late radiotherapy on the progression of heterotopic ossification following total hip arthroplasty.

Authors:  Mina Morcos; Karen Smith; Michael Tanzer
Journal:  Eur J Orthop Surg Traumatol       Date:  2018-03-21

6.  [Prospective study on the prevention of heterotopic ossification after total hip replacement. Non-steroidal anti-inflammatory agents versus radiation therapy].

Authors:  O Kölbl; M Flentje; J Eulert; T Barthel; D Knelles; U Kraus
Journal:  Strahlenther Onkol       Date:  1997-12       Impact factor: 3.621

7.  Heterotopic ossifications: role of radiotherapy as prophylactic treatment.

Authors:  Maria Grazia Ruo Redda; Chiara De Colle; Lavinia Bianco; Andrea Ruggieri; Daniela Nassisi; Annalisa Rossi; Eva Gino; Claudia Airaldi
Journal:  Radiol Med       Date:  2018-02-03       Impact factor: 3.469

8.  Prevention of heterotopic ossification in high-risk patients with total hip arthroplasty: the experience of a combined therapeutic protocol.

Authors:  Emilios E Pakos; Evita J Pitouli; Pericles G Tsekeris; Vasiliki Papathanasopoulou; Kosmas Stafilas; Theodore H Xenakis
Journal:  Int Orthop       Date:  2006-02-16       Impact factor: 3.075

9.  Perioperative high-dose-rate brachytherapy in the treatment of recurrent malignant gliomas.

Authors:  Maria Grazia Fabrini; Franco Perrone; Lucia De Franco; Francesco Pasqualetti; Silvia Grespi; Riccardo Vannozzi; Luca Cionini
Journal:  Strahlenther Onkol       Date:  2009-08-04       Impact factor: 3.621

10.  Is preoperative radiation therapy as effective as postoperative radiation therapy for heterotopic ossification prevention in acetabular fractures?

Authors:  Michael T Archdeacon; Albert d'Heurle; Nicole Nemeth; Bradley Budde
Journal:  Clin Orthop Relat Res       Date:  2014-06-04       Impact factor: 4.176

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.